tiprankstipranks
pc:tecre

TECregen

TECregen is a biotechnology company pioneering thymus rejuvenation to address conditions driven by impaired T-cell responses and immune ageing. The company develops differentiated thymopoietic biologics that revitalize and expand thymic epithelial cells (TECs) to restore immune function, support recovery after transplantation or cytotoxic therapy, and enhance immune surveillance against cancer.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$10M
Total Amount Raised$10M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$10M
Latest Funding Amount$10M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 08, 2026
Seed Round
$10.00M

Related News and Analysis